Role of Lymphoid Organs in the Pathogenesis of Human Immunodeficiency Virus (HIV) Infection
- 1 August 1994
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 140 (1) , 105-130
- https://doi.org/10.1111/j.1600-065x.1994.tb00867.x
Abstract
The pathogenic mechanisms of HIV disease are multifactorial and multi-phasic. The common denominator of the disease is the profound immunosuppression that occurs in the vast majority of infected patients. Studies in lymphoid tissues in HIV disease have provided considerable insight into the pathogenic processes involved from the earliest phases of infection through the advanced stages. Following primary infection, virus is disseminated throughout the body and seeds the lymphoid tissue where its replication is only incompletely suppressed and where a reservoir of virus is established. Extracellular virus is trapped within the FDC of the lymph node germinal centers and serves as a source of infection for cells which reside in or migrate through the lymph node throughout the course of infection even during the early and often prolonged asymptomatic period. Eventually, the architecture of the lymphoid tissue is destroyed, compounding the immune dysfunction that results from the depletion of CD4+ T cells. In this regard, the lymphoid tissue of LTNPs is relatively intact and viral burden and replication is considerably lower in the peripheral blood and lymph node mono-nuclear cells of LTNPs than in individuals whose disease progresses. Cytokines probably play a major role in the modulation of HIV expression in the milieu of the lymphoid tissue. Further understanding of the pathogenic mechanisms operative in the lymphoid tissues of HIV-infected individuals will have important implications in the design of therapeutic strategies involving both antiretroviral and immunomodulatory approaches.Keywords
This publication has 65 references indexed in Scilit:
- The role of lymphoid organs in the immunopathogenesis of HIV infectionAIDS, 1993
- Immune changes in HIV-1 infection: Significant correlations and differences in serum markers and lymphoid phenotypic antigensClinical Immunology and Immunopathology, 1992
- Cell dysfunction and depletion in AIDS: the programmed cell death hypothesisImmunology Today, 1991
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expressionImmunology Today, 1990
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Qualitative Analysis of Immune Function in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Retroviral infection of accessory cells and the immunological paradox in AIDSImmunology Today, 1985